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INTRODUCTION
Chronic urticaria (CU) is a common skin disorder that is
characterized by a 6-week or longer history of widespread,
transient, itchy cutaneous swellings, with individual lesions
lasting less than 24 hr (1). The pathogenic mechanisms of
CU are still poorly understood. However, it is now widely
accepted that CU is triggered by multiple factors, which
include autoreactivity to the high affinity immunoglobulin
E receptor (Fcε R1α ) or to immunoglobulin E (IgE) itself
(1, 2), genetic predisposition, (3, 4) hypersensitivity to drugs
or food additives (5, 6), infectious processes (7), malignancy,
and endocrine diseases (8). 
Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)
aggravate 20-30% of patients with CU (6). The pathogene-
sis of aspirin sensitivity probably involves selective inhibi-
tion of cyclooxygenase-1 and increased leukotriene synthe-
sis. The prevalence of atopy and the levels of serum total IgE
in NSAID-intolerant patients was found to be increased in
previous challenge-proven studies (9). 
Superantigens, predominantly those derived from Staphy-
lococcus aureus, can activate T cells, induce IgE synthesis by B
cells, and directly affect the activities of inflammatory leuko-
cytes, such as eosinophils. Specific IgE to staphylococcal super-
antigens has recently been associated with the pathogenesis
of various allergic conditions, e.g., atopic dermatitis (AD),
nasal polyposis, and allergic rhinitis (10, 11). In atopic der-
matitis, >50% of the patients are colonized on the skin by
superantigen-secreting S. aureus strains. Furthermore, patients
with AD often mount a systemic IgE immune response against
these exotoxins that correlates with disease severity (12, 13).
Antibodies to staphylococcal antigens have been found in
chronic urticaria (14). Potaczek et al. (15) have reported that
11 out of 34 allergic patients, including those with urticaria
and asthma, had serum IgE antibodies against the staphylo-
coccal enterotoxins staphylococcal enterotoxin A (SEA), staphy-
lococcal enterotoxin B (SEB), and toxic shock syndrome toxin
(TSST)-1. However, there are no published data on the preva-
lence of specific IgE antibodies against staphylococcal super-
antigens in CU patients or on the association between the
presence of such antibodies and the clinical phenotype of CU.
Histologic analysis of the lesions of CU patients reveals
perivascular infiltrates that contain mononuclear cells, espe-
cially CD4
+T cells, as well as variable numbers of neutrophils
845
Young-Min Ye, Gyu-Young Hur, 
Han-Jung Park, Seung-Hyun Kim, 
Hyun-Mi Kim, and Hae-Sim Park  
Department of Allergy and Rheumatology, Ajou 
University School of Medicine, Suwon, Korea
Address for correspondence
Hae-Sim Park, M.D.
Department of Allergy and Rheumatology, Ajou 
University School of Medicine, San-5 Woncheon-dong,
Yeongtong-gu, Suwon 442-721, Korea 
Tel : +82.31-219-5150, Fax : +82.31-219-5154
E-mail : hspark@ajou.ac.kr
*This study was supported by grants from the Korea
Health 21 R&D Project of the Ministry of Health & 
Welfare, Republic of Korea (03-PJ10-PG13-GD01-0002
and A050571).
J Korean Med Sci 2008; 23: 845-51
ISSN 1011-8934
DOI: 10.3346/jkms.2008.23.5.845
Copyright � The Korean Academy
of Medical Sciences
Association of Specific IgE to Staphylococcal Superantigens with 
the Phenotype of Chronic Urticaria
Received : 12 August 2007
Accepted : 29 January 2008
It has been well established that bacterial superantigens lead to the induction and
aggravation of chronic inflammatory skin diseases. We investigated the clinical
significance of serum specific immunoglobulin E (lgE) to the staphylococcal super-
antigens staphylococcal enterotoxin A (SEA), staphylococcal enterotoxin B (SEB),
and toxic shock syndrome toxin (TSST)-1 in patients with chronic urticaria (CU),
focusing on the differences in these prevalences between aspirin-intolerant CU
(AICU) and aspirin-tolerant CU (ATCU) patients. Aspirin sensitivity was confirmed
by oral aspirin provocation test. There were 66 patients AICU and 117 patients
ATCU in the study. Serum IgE antibodies specific for SEA, SEB, and TSST-1 were
measured by the ImmunoCAP test and the patients were compared with 93 nor-
mal controls (NC). The prevalences of serum specific IgE to staphylococcal super-
antigens were significantly higher in CU than in NC patients (IgE to SEA, 13.7%
vs. 5.4%; IgE to SEB, 12.0% vs. 4.3%; IgE to TSST-1, 18.0% vs. 6.5%; p< 0.05,
respectively). The patients with specific IgE to SEA, SEB, and TSST-1 had higher
serum total IgE levels and higher rates of atopy. Significant associations were
noted between the prevalence of specific IgE to SEA and SEB and the HLA DQB1*
0609 and DRB1*1302 alleles in the AICU group. We confirmed that a sub-popula-
tion of patients with CU possesses serum IgE antibodies to SEA, SEB, and TSST-
1. Particularly, the IgE immune response to TSST-1 is associated with aspirin sensi-
tivity in CU patients.
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those observed in the allergen-induced skin late-phase reac-
tion, with the exception of increased IFN-γexpression, irre-
spective of the presence of anti-Fcε R1αor anti-IgE autoan-
tibodies (17, 18). Notably, recent studies have indicated that
even the uninvolved skin of CU subjects presents an appar-
ently latent inflammatory state that is characterized by lym-
phocytic and granulocytic infiltrates (19). Sperantigens func-
tion by simultaneously interacting with class II major histo-
compatibility complex (MHC) and T cell receptor (TCR) mole-
cules on antigen presenting cells and T lymphocytes, respec-
tively. Considering engagement of TCR and MHC molecules
by superantigens is quite different from the group of which
superantigens belong to. This study was aimed also to find
any associations between specific IgE to superantigens and
HLA markers of aspirin senstitivity in patients with CU (20).
Therefore, we evaluated the clinical significance of serum
specific IgE to the staphylococcal superantigens SEA, SEB,
and TSST-1 in patients with CU, focusing on the differences
in these prevalences between aspirin-intolerant CU (AICU)
and aspirin-tolerant CU (ATCU) patients.
MATERIALS AND METHODS
Subjects
This study included 183 CU patients (89 males and 94
females, age range 15-74 yr mean age 39 yr) who were fol-
lowed in the outpatient Allergy & Rheumatology Clinics of
Ajou University Medical Center. The AICU were defined as
patients who had a definite history of urticaria/angioedema
development after the ingestion of more than two types of
NSAID and positive responders in the oral aspirin challenge
test, classified as the cross-reacting group by Sanchez-Borges
et al. (9) In addition, NSAID sensitivity could be confirmed,
as the patients presented at our Allergy Clinics or emergency
rooms with current urticaria/angioedema after taking NSAIDs.
Patients who manifested both aspirin-intolerant asthma
(AIA) and aspirin intolerant urticaria (AIU) were excluded
from this study. In all, 93 normal control (NC) subjects (39
males and 54 females, age range 18-67 yr, mean age 35 yr)
who had no personal or family history of allergic diseases,
and no past history of aspirin or other drug hypersensitivity,
were recruited from the general population. Informed con-
sent was obtained from each patient and the study protocol
was approved by the ethics committee of Ajou University
Medical Center, Suwon, Korea.
Allergy skin prick test
Skin prick tests were performed with 50 common aeroal-
lergens (Bencard, Brentford, U.K.), which included Der-
matophagoides pteronyssinus, D. farine, cat, dog, cockroach, tree
pollen mixture, grass pollen mixture, mugwort, ragweed,
Hummulus japonicus, Aspergillus, Alternaria, histamine, and
a saline control. The reactions were read after 15 min, and
the wheal was measured in two directions. A positive reac-
tion was defined as a mean wheal diameter of ≥3 mm. Atopy
was defined as a positive skin test response to at least one
common inhalant allergen.
Oral provocation test with aspirin
All medications, including anti-histamines, steroids, and
leukotriene receptor antagonists, were stopped 72 hr before
the procedure. After the placebo challenge, 500 mg of aspirin
(Rhonal
�; KunWha Pharmaceutical Co., Seoul, Korea) in
tablet form was administered orally, and the patients were
observed for 4 hr, with monitoring of urticaria, angioedema,
and changes in lung function every 30 min. The appearance
of urticaria within 4 hr without any change in FEV1 was con-
sidered a positive result.
Measurements of total and specific IgE
The levels of total IgE and specific IgE directed against
SEA, SEB, and TSST-1 were measured by the ImmunoCAP
system (Pharmacia Diagnostics, Uppsala, Sweden) accord-
ing to the manufacturer’s instructions.
Genomic DNA preparation and high-resolution human
leukocyte antigen (HLA) genotyping
HLA DRB1 and DQB1 typing was carried out by direct
DNA sequencing only in AICU group. The procedures and
primers for PCR amplification and sequencing of the HLA-
DRB1 and DQB1 alleles have been described previously
(21). 
Statistical analysis 
Intergroup comparisons of the prevalences of specific IgE
antibodies to SEA, SEB, and TSST-1, and for categorical clin-
ical parameters, were performed using the chi-square test or
Fisher’s exact tests, with adjustments for multiple compar-
isons. Analysis of variance (ANOVA) followed by post-hoc
Dunnett’s T3 was applied to compare the demographic data
and mean levels of total IgE among the three study groups.
Continuous variables that did not have a normal distribution,
such as the levels of serum total IgE, were log-transformed.
For comparisons of clinical parameters and HLA markers
according to the results of specific IgE against superantigens
in patients with AICU, the chi-square test or Fisher’s exact
test was used. A p value ≤0.05 was regarded as being sta-
tistically significant. The statistical analyses were performed
using the SPSS 12.0 for Windows software (SPSS Inc., Chica-
go, IL, U.S.A.). 
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Clinical characteristics of the study subjects
For the AICU patients, the atopy rate and the mean total
serum IgE level were 70.5% and 302.8 IU/mL, respectively,
which were significantly higher than the values for the ATCU
patients (p=0.016 and p=0.043, respectively). However,
there was no significant difference in the prevalence of aller-
gic diseases and the duration of urticaria according to aspirin
sensitivity. The characteristics of the subjects are shown in
Table 1. 
Prevalences of superantigen-specific IgE
Specific IgE for SEA, SEB, and TSST-1 was detected in
14.6%, 13.1%, and 19.8% of the CU patients and in about
5% of the NC patients (p=0.041, p=0.049, and p=0.001,
respectively). When the prevalences of specific IgE to the
three staphylococcal superantigens were compared among
the ATCU, AICU, and NC groups, the highest values were
noted for the AICU patients (18.2% for SEA, 16.7% for SEB,
25.8% for TSST-1), followed by ATCU (11.1% for SEA,
9.4% for SEB, 13.7% for TSST-1), and NC (5.4% for SEA,
4.3% for SEB, 6.5% for TSST-1). Moreover significant differ-
ences were noted between the AICU and NC groups (p=0.001
for SEA and TSST-1, p=0.013 for SEB; Fig. 1). The specific
IgE to TSST-1 was the most prevalent in AICU pati- ents, and
statistical significance was noted in comparison with ATCU
patients (p=0.047). However, no significant difference in the
prevalence of specific serum IgE to superantigens was noted
in the comparison of the ATCU and NC groups.
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AICU
N=66 (%)
ATCU
N=117 (%)
NC
N=93 (%)
Sex (M/F) 32/34 57/60 39/54
Age (yr)
� 36.7±12.6 39.8±11.5 29.2±9.9
Atopy (%)
� 43/61 (70.5) 58/113 (51.3) 24/79 (30.4)
Total IgE (IU/mL) 302.8±352 206.9±252 125.0±230
Duration (months) 28.74±49.5 39.06±64.3 NA
Allergic diseases* 30 (45.5) 39 (33.3) NA
Table 1. Demographics of the study groups
Fig. 1. Prevalences of serum specific IgE to staphylococcal super-
antigens When the prevalences of specific IgE to the three staphy-
lococcal superantigens were compared among the AICU, ATCU
and NC groups, the highest values were noted for the AICU patients
(18.2% for SEA, 16.7% for SEB, 25.8% for TSST-1, 31.8% for any
SEs). Moreover significant differences were noted between the
AICU and NC groups (p=0.001 for SEA and TSST-1, p=0.013 for
SEB). The specific IgE to TSST-1 was the most prevalent in AICU
patients, and statistical significance was noted in comparison with
ATCU patients (p=0.047).
AICU, aspirin-intolerant chronic urticaria; ATCU, aspirin-tolerant
chronic urticaria; NC, normal control; SEA, staphylococcal entero-
toxin A; SEB, staphylococcal enterotoxin B; TSST-1, toxic shock
syndrome toxin-1; SEs, staphylococcal enterotoxins; NS, not sig-
nificant.
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Any SEs
5.4 4.3
6.5
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22.2
p=0.013
p=0.001
IgE to
SEA
Positive
N=25
Negative
N=158
SEB
Positive
N=22
Negative
N=161
TSST-1
Positive
N=33
Negative
N=150
SEA or SEB or TSST-1
Positive
N=47
Negative
N=136
Sex (male, %) 17 (68.0) 72 (45.6) 14 (63.6) 75 (46.6) 15 (45.5) 74 (49.3) 24 (54.1) 65 (47.8)
Age (yr) 42.0±12.2 38.6±11.9 42.2±12.4 38.2±11.9 38.7±10.7 38.7±12.3 38.8±11.9 38.7±12.0
Atopy (%) 20 (87.0)* 81 (53.6) 17 (77.3) 84 (55.3) 26 (78.8)* 75 (53.2) 36 (78.3) 67 (51.1)
Log (total IgE [IU/mL]) 2.67±0.3
� 2.08±0.4 2.54±0.4
� 2.11±0.4 2.42±0.4
� 2.11±0.4 2.44±0.4
� 2.07±0.4
Duration of urticaria  62.0±99.0 28.8±50.4 81.7±107.5 26.7±46.8 53.5±70.5 29.0±55.7 52.9±81.8 26.6±48.4
(months)
Asthma (%) 3 (12.0) 10 (6.3) 1 (4.5) 12 (7.5) 3 (9.1) 10 (6.7) 6 (13.3) 8 (6.0)
Rhinitis (%) 11 (44.0) 54 (34.2) 8 (36.4) 57 (35.4) 11 (33.3) 54 (36.0) 20 (44.4) 46 (34.3)
Table 2. Comparison of clinical parameters according to specific IgE to Staphylococcal superantigens in 183 chronic urticaria patients
*p<0.05 for positive IgE to SEA and TSST-1 compared with the respective negative counterpart (chi-square test); 
� p<0.001 for positive IgE to SEA,
SEB, and TSST-1 compared with the respective negative counterpart (chi-square test).
SEA, staphylococcal enterotoxin A; SEB, staphylococcal enterotoxin B; TSST-1, toxic shock syndrome toxin-1. 
*Allergic diseases indicate that the subject had one or more of associat-
ed diseases including allergic asthma and allergic rhinitis; 
� , p<0.05 for
NC vs. AICU or ATCU (ANOVA); 
� , p<0.016 for AICU vs. ATCU and p<
0.01 for NC vs. AICU or ATCU (chi-square test). 
AICU, aspirin-intolerant chronic urticaria; ATCU, aspirin-tolerant chronic
urticaria; NC, normal control; IgE, immunoglobin E; NA, not assessable. Stratification for sensitization to staphylococcal enterotoxins
Irrespective of their AICU and ATCU statuses, all 183
subjects were stratified for the presence or absence of serum
IgE specific for SEA, SEB, and TSST-1 (Table 2). Subjects
who were positive for IgE specific for three superantigens
did not differ from those who were negative for each super-
antigen-specific IgE in terms of gender ratio, age, and the
duration of urticaria. However, the subjects with IgE to super-
antigens had remarkably higher levels of total IgE (p<0.001,
for all three superantigens). The subjects who had specific IgE
to SEA or TSST-1 had significantly higher atopy rates com-
pared to those subjects who were negative for specific IgE to
SEA or TSST-1 (p=0.003 for SEA and p=0.010 for TSST-1). 
Association between IgE to staphylococcal enterotoxins
and the presence of HLA DQB1*0609 and DRB1*1302
alleles in patients with AICU
The presence of specific IgE to SEA was significantly asso-
ciated with the presence of HLA DQB1*0609 (p=0.026,
odds ratio=8.38) and HLA DRB1*1302 (p=0.039, odds
ratio [OR], 5.69) in AICU patients (Table 3). A significant
association was also noted for specific IgE to SEB and HLA
DQB1*0609 (p=0.026, OR, 8.38). However, no significant
associations were found between the presence of IgE to TSST-
1 and HLA DRB1*1302 or DQB1*0609 (p>0.05 in each
case). 
DISCUSSION
This study is the first to demonstrate that the sera from
25.7% of CU patients contain specific IgE for one or more
of the staphylococcal superantigens SEA, SEB, and TSST-1.
In particular, compared with healthy controls, a significant-
ly greater proportion of the AICU patients had serum IgE to
either enterotoxins or TSST-1. However, some of the ATCU
patients had specific IgE to superantigens, the prevalences
of which did not differ from those of normal controls. With
respect to IgE to individual staphylococcal toxins, IgE to
TSST-1 was most prevalent in all three groups. A significant
difference was noted for the prevalence of IgE to TSST-1 in
AICU patients, compared with NC or ATCU patients. The
evidence of IgE antibodies to these staphylococcal superanti-
gens in the sera of CU patients, and the notable prevalence
of these antibodies in the AICU group, suggest a link between
allergy and infection in this disease. Since HLAs play a major
role in regulating immune responses, a significant associa-
tion between IgE to SEA or SEB and AICU-related HLA
markers, which include HLA DQB1*0609 and DRB1*
1302, strengthen this hypothesis. However, IgE to TSST-1,
which was the most prevalent form in AICU patients, was
not associated with these two HLA alleles. Given that we
selectively targeted these two HLA alleles based on a previ-
ous study on the association of HLA alleles with aspirin-intol-
erant urticaria in a Korean population (21), it is possible that
the IgE immune response to TSST-1 is influenced by other
HLA molecules. As proven that more than 30 distinct super-
antigens are identified. Although they share a conserved ter-
tiary structure, there exist key differences in how the charac-
terized representatives for each superantigen engage their host
receptors. Among superantigens, TSST-1 is the unique in
that it binds MHC through an N-terminal, low-affinity bind-
ing domain that is peptide-dependent. However, this study
has some limitations to identify the association of specific
IgE to staphylococcal superantigens and their recognition by
immune system. The first our analysis was performed about
two HLA markers, HLA DRB1*1302 and HLA DQB1*
0609. The second, only the subjects with AICU group were
involved in genotyping of HLA markers. Therefore, further
study involving other HLA markers particularly associated
with TSST-1 and expanded patients population to ATCU
would be necessary to clarify the association between HLA
markers and IgE immune response to staphylococcal super-
antigens. 
The potential role of superantigens in immune-mediated
inflammatory skin disease is an area of intense investigation.
Superantigens potently and specifically activate a large pro-
portion of T cells, resulting in the release of T-helper (Th) 2
cytokines as well as increased IgE synthesis and eosinophilia
(22). Leung et al. (23) have demonstrated that 57% of AD
patients have circulating IgE to staphylococcal superantigens
and that their own basophils release histamine upon exposure
to the relevant enterotoxins but not in response to entero-
toxins, against which there is no IgE response. While colo-
nization by S. aureus has been reported for 2-25% of normal
skin sites (24) and patients with psoriasis experience frequent
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*p values were determined by the chi-square test with continuity cor-
rection or Fisher’s exact test.
SEA, staphylococcal enterotoxin A; SEB, staphylococcal enterotoxin B;
TSST-1, toxic shock syndrome toxin-1; HLA, human leukocyte antigen;
IgE, immunoglobulin E; OR, odds ratio; CI, confidence interval; NS, not
significant.
IgE to
p*
(OR, 95%CI)
DQB1*0609
Posi-
tive
Nega-
tive
p*
(OR, 95%CI)
DRB1*1302
Posi-
tive
Nega-
tive
SEA + 4 7 0.026 (8.38, 5 6 0.039 (5.69,
- 3 44 1.54-45.7) 6 41 1.32-24.6)
SEB + 4 7 0.026 (8.38, 4 7 0.227 (3.27,
- 3 44 1.54-45.7) 7 40 0.75-14.2)
TSST-1 + 3 14 NS 3 14 NS
- 43 7 83 3
Table 3. Association between HLA alleles and specific IgE to
staphylococcal superantigens in 58 aspirin-intolerant chronic
urticaria (AICU) patientsSerum Specific IgE to Staphylococcal Superantigen in Chronic Urticaria 849
exacerbation due to staphylococcal infection, IgE specific for
staphylococcal enterotoxins has not been detected in the sera
of these patients (23). These findings support the notion that
IgE antibodies to superantigens induce the degranulation of
mast cells and basophils, with consequent release of media-
tors, cytokines, and chemokines, which results in sustained
tissue inflammation in a subpopulation of CU patients, as
seen for a subset of AD patients. However, our preliminary
experiment which evaluated the degree of colonization with
S. aureus from the skin of AICU patients (n=13) showed no
significant difference from that of healthy controls (n=9) (p>
0.05, Fisher’s exact test). We performed bacterial swabs from
the skin and the anterior nares of subjects. Three of the patients
with AICU harbored S. aureus in their nares and none of them
had cutaneous colonization of the strain. Among healthy con-
trols, three harbored the strain in their nares and two had
cutaneous colonization. But, there was no significant associ-
ation between the degree of colonization and the presence of
serum IgE specific for staphylococcal superantigens (data not
shown), suggesting that skin colonization of S. aureus could
not affect on IgE sensitization to staphylococcal superantigens
in AICU patients.
In the present study, the patients with IgE specific for
staphylococcal superantigens had higher total IgE levels and
higher rates of atopy than patients without serum IgE spe-
cific for superantigens. These significant differences in total
IgE levels and atopy rates were found in comparisons of AICU
and ATCU patients. On that point, this study has some limi-
tations that the atopic status of patients might affect on IgE
sensitization to staphylococcal superantigens than the effect
of aspirin sensitivity. However, after adjustment for the poten-
tial confounding effect of total serum IgE levels and atopic
status, the prevalence of IgE specific for TSST-1 was still sig-
nificantly associated with the AICU phenotype. Moreover,
there were no significant differences in the prevalence of aller-
gic diseases including allergic asthma, allergic rhinitis and
atopic dermatitis between AICU and ATCU groups in this
study. We could not find any significant difference in the
prevalence of allergic diseases according to the presence or
absence of specific IgE to superantigens. These results sug-
gested that in CU subjects their accompanying allergic dis-
eases did not affect on IgE immune responses to staphylo-
coccal superantigens. 
There is no evidence to suggest that aspirin sensitivity is
directly related to an immune response to superantigens,
previous studies on the pathogenesis of nasal polyposis in
aspirin-sensitive subjects provide some clues (25, 26). We
have previously demonstrated the presence of IgE specific
for staphylococcal superantigens in nasal polyp tissues, and
shown that the IgE levels correlate with eosinophil-related
markers. Moreover, the levels of superantigen-specific IgE
were markedly elevated in the nasal polyps of subjects with
AIA, as compared to patients with aspirin-tolerant asthma
(ATA) (26). Recently, it has been reported that cysteinyl
leukotriene production is up-regulated in the polyp tissues
of patients with IgE to superantigens, and that these levels
correlate with the presence of an eosinophilic inflammation
marker and specific IgE to staphylococcal enterotoxins (27).
On the other hand, histologic examinations of CU patients
have demonstrated perivascular infiltrations of mixed Th1/
Th2 cells, eosinophils, and increased IL-4, IL-5, and IFN-γ
mRNA expression, similar to what has been observed in
chronic AD skin (18). Furthermore, deposition of major
basic protein (MBP) and eosinophil cationic protein (ECP)
has been observed outside of eosinophils in skin specimens
from patients with CU, as has also been seen for involved
tissue specimens from patients with various allergic diseases,
including asthma, AD, and nasal polyps. Though this study
could not evaluate how the presence of specific IgE to staphy-
lococcal superantigens modified the clinical course, such as
the severity or exacerbation rate, of CU, because there has
been no standard severity index for patients with CU. Taken
together, our results suggest that IgE directed against staphy-
lococcal superantigens trigger and perpetuate eosinophilic
and T cell-mediated allergic inflammation in some CU
patients, as has been observed previously for patients with
AD, nasal polyps, and asthma. 
Various studies have indicated that urticaria has a complex
physiopathology that involves multiple inflammatory path-
ways. However, it is generally considered that the interac-
tion between IgE-bound mast cells and allergens is unlikely
to be the mechanism by which urticaria develops in most
patients. Most studies on the pathogenesis of CU have focused
on the autoimmune mechanisms and features, including the
anti-Fcε R1α , anti-IgE, and anti-thyroid autoantibodies.
However, these autoimmune responses have been document-
ed in only about 50% of patients with CU. Previous studies
have indicated that the atopic condition may represent an
important risk factor for the development or aggravation of
urticaria in response to aspirin or NSAIDs. In particular, the
results of our recent study on Fcε R1αpromoter polymor-
phisms suggest that prolonged exposure to IgE induces the
persistent accumulation and activation of mast cells and baso-
phils via increased surface expression of high-affinity IgE recep-
tors in AICU patients (28). Furthermore, recent studies have
demonstrated that TSST-1, which is a prototypic superanti-
gen, has an adjuvant effect on IgE synthesis through several
mechanisms, such as the up-regulation of the B7.2 molecule
and CD40 ligand on B and T cells, respectively (29, 30).
TSST-1 is unique among staphylococcal toxins in its ability
to cross mucosal surfaces, due its high content of hydropho-
bic amino acids (31). This is consistent with the results of the
present study in that IgE specific for TSST-1 was the most
prevalent IgE type in the urticaria groups. In this regard,
aspirin sensitivity may have synergistic effects on leukotrienes
and eosinophil-mediated inflammation, as well as on mast
cell activation in CU patients who carry serum IgE to TSST-1. 
From the literature, it is clear that the prevalence of infec-tions, whether bacterial, viral, parasitic or fungal, appears
not different from the general population. However, there
are several reports that demonstrate the benefit of eradicat-
ing the infectious process (7). As data on the beneficial effects
for AICU patients of leukotriene receptor antagonist in com-
bination with antihistamines is increasing, the use of antibi-
otics to decrease staphylococcal colonization, with concomi-
tant reductions in the levels of staphylococcal toxins, may
be useful in the treatment of CU patients with serum IgE
to superantigens. 
In conclusion, we have identified a subset of CU patients
with serum IgE antibodies to staphylococcal superantigens.
Although the statistical significance was not found, the preva-
lences of specific IgE to superantigens were higher in patients
with AICU than in ATCU patients. We propose that the
IgE immune response to TSST-1 is associated with aspirin
sensitivity in CU patients. Further study is necessary to con-
firm how these IgE antibodies with specificity for staphylo-
coccal superantigens are involved in the pathogenesis of CU. 
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